Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Objective The purpose of this article is to discuss the use, comparative efficacy, and
research progress of radiofrequency ablation (RFA), alone or in combination with other …

Hepatocellular carcinoma (HCC) is one of the most common malignancies globally, and is
frequently associated with a poor prognosis. 5-methylcytosine (m 5 C) is a common …

Background & Aims Radiofrequency ablation (RFA) and ablative external beam
radiotherapy (ablative RT) are commonly used to treat small intrahepatic malignancies. We …

Objectives The purpose of this study was to evaluate the 10-year overall survival and local
tumor progression (LTP) of percutaneous radiofrequency ablation (RFA) for single nodular …

Objectives We aimed to compare the therapeutic outcomes of radiofrequency ablation (RFA)
and microwave ablation (MWA) as first-line therapies in patients with small single …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Background: Treatment outcomes of laparoscopic liver resection (LLR) and percutaneous
radiofrequency ablation (p-RFA) for small single hepatocellular carcinomas (HCCs) have …

The existence of inadequate ablation remains an important cause of treatment failure for
loco‐regional ablation therapies. Here, using a preclinical model, it is reported that …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …